The warning letter, issued on March 30 following a September 2025 inspection, says the company’s manufacturing practices have failed to comply with good manufacturing norms ...
FDA has also sent several Form 483s, the precursor to most Warning Letters, to Indian companies such as one to Ranbaxy in January 2014. The letters stick out because unlike manufacturing ...
FDA Warns Pan Over Data Integrity, Sanitation Issues For the second time in less than a year, the US Food and Drug Administration (FDA) has issued a warning letter to Indian active pharmaceutical ...
Two-day training with real-world cases and practical application organized in collaboration with Prescription Pharma Support in Istanbul aims to boost Türkiye’s pharmaceutical industry's competitive e ...
The Center for Drug Evaluation and Research (CDER), a division of the US Food and Drug Administration (FDA), has expressed ...
Pharmaceutical major Pfizer has been issued a warning letter by US FDA on issues of failed sterility test, Environmental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results